 | • レポートコード：QYR9ST02676 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のソラフェニブ市場について調査・分析し、以下の構成でお届け致します。ソラフェニブの種類別には、特許薬、一般薬に、用途別には、腎臓がん、肝臓がん、甲状腺がん、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別ソラフェニブ売上データ ・地域別ソラフェニブ市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別ソラフェニブ市場規模：特許薬、一般薬 ・用途別ソラフェニブ市場規模：腎臓がん、肝臓がん、甲状腺がん、その他 ・主要メーカーの企業情報：Bayer、Natco Pharma、Cipla、Mylan ・ソラフェニブの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The global Sorafenib market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sorafenib market based on company, product type, end user and key regions.
This report studies the global market size of Sorafenib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sorafenib in these regions.
This research report categorizes the global Sorafenib market by top players/brands, region, type and end user. This report also studies the global Sorafenib market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Natco Pharma
Cipla
Mylan
Market size by Product
Patented Drugs
Generic Drugs
Market size by End User
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sorafenib market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sorafenib market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sorafenib companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sorafenib submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sorafenib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sorafenib market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Sorafenib Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Sorafenib Market Size Growth Rate by Product
1.4.2 Patented Drugs
1.4.3 Generic Drugs
1.5 Market by End User
1.5.1 Global Sorafenib Market Size Growth Rate by End User
1.5.2 Kidney Cancer
1.5.3 Liver Cancer
1.5.4 Thyroid Cancer
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Sorafenib Market Size
2.1.1 Global Sorafenib Revenue 2014-2025
2.1.2 Global Sorafenib Sales 2014-2025
2.2 Sorafenib Growth Rate by Regions
2.2.1 Global Sorafenib Sales by Regions
2.2.2 Global Sorafenib Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Sorafenib Sales by Manufacturers
3.1.1 Sorafenib Sales by Manufacturers
3.1.2 Sorafenib Sales Market Share by Manufacturers
3.1.3 Global Sorafenib Market Concentration Ratio (CR5 and HHI)
3.2 Sorafenib Revenue by Manufacturers
3.2.1 Sorafenib Revenue by Manufacturers (2014-2019)
3.2.2 Sorafenib Revenue Share by Manufacturers (2014-2019)
3.3 Sorafenib Price by Manufacturers
3.4 Sorafenib Manufacturing Base Distribution, Product Types
3.4.1 Sorafenib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sorafenib Product Type
3.4.3 Date of International Manufacturers Enter into Sorafenib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Sorafenib Sales by Product
4.2 Global Sorafenib Revenue by Product
4.3 Sorafenib Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Sorafenib Breakdown Data by End User
6 North America
6.1 North America Sorafenib by Countries
6.1.1 North America Sorafenib Sales by Countries
6.1.2 North America Sorafenib Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Sorafenib by Product
6.3 North America Sorafenib by End User
7 Europe
7.1 Europe Sorafenib by Countries
7.1.1 Europe Sorafenib Sales by Countries
7.1.2 Europe Sorafenib Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sorafenib by Product
7.3 Europe Sorafenib by End User
8 Asia Pacific
8.1 Asia Pacific Sorafenib by Countries
8.1.1 Asia Pacific Sorafenib Sales by Countries
8.1.2 Asia Pacific Sorafenib Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Sorafenib by Product
8.3 Asia Pacific Sorafenib by End User
9 Central & South America
9.1 Central & South America Sorafenib by Countries
9.1.1 Central & South America Sorafenib Sales by Countries
9.1.2 Central & South America Sorafenib Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Sorafenib by Product
9.3 Central & South America Sorafenib by End User
10 Middle East and Africa
10.1 Middle East and Africa Sorafenib by Countries
10.1.1 Middle East and Africa Sorafenib Sales by Countries
10.1.2 Middle East and Africa Sorafenib Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Sorafenib by Product
10.3 Middle East and Africa Sorafenib by End User
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Business Overview
11.1.3 Bayer Sorafenib Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer Sorafenib Products Offered
11.1.5 Bayer Recent Development
11.2 Natco Pharma
11.2.1 Natco Pharma Company Details
11.2.2 Company Business Overview
11.2.3 Natco Pharma Sorafenib Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Natco Pharma Sorafenib Products Offered
11.2.5 Natco Pharma Recent Development
11.3 Cipla
11.3.1 Cipla Company Details
11.3.2 Company Business Overview
11.3.3 Cipla Sorafenib Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cipla Sorafenib Products Offered
11.3.5 Cipla Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Business Overview
11.4.3 Mylan Sorafenib Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Mylan Sorafenib Products Offered
11.4.5 Mylan Recent Development
12 Future Forecast
12.1 Sorafenib Market Forecast by Regions
12.1.1 Global Sorafenib Sales Forecast by Regions 2019-2025
12.1.2 Global Sorafenib Revenue Forecast by Regions 2019-2025
12.2 Sorafenib Market Forecast by Product
12.2.1 Global Sorafenib Sales Forecast by Product 2019-2025
12.2.2 Global Sorafenib Revenue Forecast by Product 2019-2025
12.3 Sorafenib Market Forecast by End User
12.4 North America Sorafenib Forecast
12.5 Europe Sorafenib Forecast
12.6 Asia Pacific Sorafenib Forecast
12.7 Central & South America Sorafenib Forecast
12.8 Middle East and Africa Sorafenib Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sorafenib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Sorafenib Product Picture
Table Sorafenib Market Segments
Table Key Manufacturers Sorafenib Covered
Table Global Sorafenib Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Sorafenib Sales Market Share by Product 2014-2025
Figure Patented Drugs Product Picture
Table Major Manufacturers of Patented Drugs
Figure Generic Drugs Product Picture
Table Major Manufacturers of Generic Drugs
Table Global Sorafenib Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Kidney Cancer
Figure Liver Cancer
Figure Thyroid Cancer
Figure Other
Figure Sorafenib Report Years Considered
Figure Global Sorafenib Market Size 2014-2025 (Million US$)
Figure Global Sorafenib Sales 2014-2025 (K Units)
Table Global Sorafenib Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Sorafenib Sales by Regions 2014-2019 (K Units)
Table Global Sorafenib Sales Market Share by Regions 2014-2019
Figure Global Sorafenib Sales Market Share by Regions 2014-2019
Figure 2018 Global Sorafenib Sales Market Share by Regions
Table Global Sorafenib Revenue by Regions 2014-2019 (Million US$)
Table Global Sorafenib Revenue Market Share by Regions 2014-2019
Figure Global Sorafenib Revenue Market Share by Regions 2014-2019
Figure 2018 Global Sorafenib Revenue Market Share by Regions
Table Global Sorafenib Sales by Manufacturers (2014-2019) (K Units)
Table Global Sorafenib Sales Share by Manufacturers (2014-2019)
Figure Global Sorafenib Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Sorafenib Revenue by Manufacturers (2014-2019) (Million USD)
Table Sorafenib Revenue Share by Manufacturers (2014-2019)
Figure Sorafenib Value Share by Manufacturers in 2018
Table Key Manufacturers Sorafenib Price (2014-2019) (USD/Unit)
Table Sorafenib Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Sorafenib Product Type
Table Date of International Manufacturers Enter into Sorafenib Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Sorafenib Sales by Product (2014-2019) (K Units)
Table Global Sorafenib Sales Share by Product (2014-2019)
Figure Global Sorafenib Sales Market Share by Product (2014-2019)
Figure Global Sorafenib Sales Market Share by Product in 2018
Table Global Sorafenib Revenue by Product (2014-2019) (Million US$)
Table Global Sorafenib Revenue Share by Product (2014-2019)
Figure Global Sorafenib Revenue Market Share by Product (2014-2019)
Figure Global Sorafenib Revenue Market Share by Product in 2018
Table Sorafenib Price by Product 2014-2019 (USD/Unit)
Table Global Sorafenib Sales by End User (2014-2019) (K Units)
Table Global Sorafenib Sales Share by End User (2014-2019)
Figure Global Sales Sorafenib Market Share by End User (2014-2019)
Figure Global Sales Sorafenib Market Share by End User in 2018
Figure North America Sorafenib Sales Growth Rate 2014-2019 (K Units)
Figure North America Sorafenib Revenue Growth Rate 2014-2019 (Million US$)
Table North America Sorafenib Sales by Countries (2014-2019) (K Units)
Table North America Sorafenib Sales Market Share by Countries (2014-2019)
Figure 2018 North America Sorafenib Sales Market Share by Countries
Table North America Sorafenib Revenue by Countries (2014-2019) (Million US$)
Table North America Sorafenib Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Sorafenib Revenue Market Share by Countries
Figure United States Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure United States Sorafenib Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Canada Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Table North America Sorafenib Sales by Product (2014-2019) (K Units)
Table North America Sorafenib Sales Market Share by Product (2014-2019)
Figure 2018 North America Sorafenib Market Share by Product
Table North America Sorafenib Sales by End User (2014-2019) (K Units)
Table North America Sorafenib Sales Market Share by End User (2014-2019)
Figure 2018 North America Sorafenib Market Share by End User
Figure Europe Sorafenib Sales Growth Rate 2014-2019 (K Units)
Figure Europe Sorafenib Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Sorafenib Sales by Countries (2014-2019) (K Units)
Table Europe Sorafenib Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Sorafenib Sales Market Share by Countries
Table Europe Sorafenib Revenue by Countries (2014-2019) (Million US$)
Table Europe Sorafenib Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Sorafenib Revenue Market Share by Countries
Figure Germany Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Germany Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure France Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure France Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure UK Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Italy Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Russia Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Sorafenib Sales by Product (2014-2019) (K Units)
Table Europe Sorafenib Sales Market Share by Product (2014-2019)
Figure 2018 Europe Sorafenib Market Share by Product
Table Europe Sorafenib Sales by End User (2014-2019) (K Units)
Table Europe Sorafenib Sales Market Share by End User (2014-2019)
Figure 2018 Europe Sorafenib Market Share by End User
Figure Asia Pacific Sorafenib Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Sorafenib Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Sorafenib Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Sorafenib Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Sorafenib Sales Market Share by Countries
Table Asia Pacific Sorafenib Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Sorafenib Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Sorafenib Revenue Market Share by Countries
Figure China Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure China Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Japan Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Korea Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure India Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure India Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Australia Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Sorafenib Sales by Product (2014-2019) (K Units)
Table Asia Pacific Sorafenib Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Sorafenib Market Share by Product
Table Asia Pacific Sorafenib Sales by End User (2014-2019) (K Units)
Table Asia Pacific Sorafenib Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Sorafenib Market Share by End User
Figure Central & South America Sorafenib Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Sorafenib Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Sorafenib Sales by Countries (2014-2019) (K Units)
Table Central & South America Sorafenib Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Sorafenib Sales Market Share by Countries
Table Central & South America Sorafenib Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Sorafenib Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Sorafenib Revenue Market Share by Countries
Figure Brazil Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Sorafenib Sales by Product (2014-2019) (K Units)
Table Central & South America Sorafenib Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Sorafenib Market Share by Product
Table Central & South America Sorafenib Sales by End User (2014-2019) (K Units)
Table Central & South America Sorafenib Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Sorafenib Market Share by End User
Figure Middle East and Africa Sorafenib Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Sorafenib Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Sorafenib Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Sorafenib Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Sorafenib Sales Market Share by Countries
Table Middle East and Africa Sorafenib Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Sorafenib Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Sorafenib Revenue Market Share by Countries
Figure GCC Countries Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Sorafenib Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Sorafenib Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Sorafenib Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Sorafenib Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Sorafenib Market Share by Product
Table Middle East and Africa Sorafenib Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Sorafenib Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Sorafenib Market Share by End User
Table Bayer Company Details
Table Bayer Sorafenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Natco Pharma Company Details
Table Natco Pharma Sorafenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Natco Pharma Recent Development
Table Cipla Company Details
Table Cipla Sorafenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cipla Recent Development
Table Mylan Company Details
Table Mylan Sorafenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Global Sorafenib Sales Forecast by Regions 2019-2025 (K Units)
Table Global Sorafenib Sales Market Share Forecast by Regions 2019-2025
Table Global Sorafenib Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Sorafenib Revenue Market Share Forecast by Regions 2019-2025
Table Global Sorafenib Sales Forecast by Product 2019-2025 (K Units)
Table Global Sorafenib Sales Market Share Forecast by Product 2019-2025
Table Global Sorafenib Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Sorafenib Revenue Market Share Forecast by Product 2019-2025
Table Global Sorafenib Sales Forecast by End User 2019-2025 (K Units)
Table Global Sorafenib Sales Market Share Forecast by End User 2019-2025
Figure North America Sorafenib Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Sorafenib Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Sorafenib Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Sorafenib Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Sorafenib Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Sorafenib Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Sorafenib Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Sorafenib Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Sorafenib Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Sorafenib Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Sorafenib Value Chain
Table Sorafenib Customers List
Table Sorafenib Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
腎臓癌治療薬の世界市場：市場規模・現状・予測 Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. In 2018, the gl…- 胃腸癌治療薬の世界市場：インサイト・予測 Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected …
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …